neuropeptide Y



neuropeptide Y

Y1YY1P2PP2S3SS3K4KK4P5PP5D6DD6N7NN7P8PP8G9GG9E10EE10D11DD11A12AA12P13PP13A14AA14E15EE15D16DD16M17MM17A18AA18R19RR19Y20YY20Y21YY21S22SS22A23AA23L24LL24R25RR25H26HH26Y27YY27I28II28N29NN29L30LL30I31II31T32TT32R33RR33Q34QQ34R35RR35Y36YY36

SMILES None
InChIKey XKWCTHKJQNUFOQ-HRPSIEBRSA-N
Sequence YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


Bioactivities

neuropeptide Y

Y1YY1P2PP2S3SS3K4KK4P5PP5D6DD6N7NN7P8PP8G9GG9E10EE10D11DD11A12AA12P13PP13A14AA14E15EE15D16DD16M17MM17A18AA18R19RR19Y20YY20Y21YY21S22SS22A23AA23L24LL24R25RR25H26HH26Y27YY27I28II28N29NN29L30LL30I31II31T32TT32R33RR33Q34QQ34R35RR35Y36YY36

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.